Owner-User Industrial Advisory | Life Sciences & Pharma

For pharmaceutical, life sciences, and healthcare operators, facility ownership is

often a strategic operating decision, not simply a real estate investment.

We advise owner-occupants on acquisition, disposition, and long-term facility planning with a deep understanding of regulatory exposure, capital structure, operational

risk, and enterprise governance.

Our owner-user advisory includes:

• Acquisition and disposition of owner-occupied industrial and flex assets
• SBA and owner-user financing strategy support
• Facility, expansion, and consolidation planning
• Lease-versus-own analysis
• Long-term operational and regulatory risk assessment

We evaluate real estate decisions through the lens of business continuity, scalability, and integration with internal legal, QA, and compliance teams.

• Pharmaceutical manufacturers and distributors
• Life sciences and medical device companies
• Cold-chain and regulated logistics operators
• Healthcare manufacturing and specialty distribution users

We focus on durability, flexibility, and enterprise alignment, whether acquiring a first

facility or optimizing a long-held asset.

Owner-occupied pharmaceutical and life sciences facilities carry:

• High build-out and compliance costs
• Long operational time horizons
• Regulatory and quality risk
• Limited reuse optionality

We structure transactions to protect downside risk while supporting long-term

growth.

If facility ownership is part of your long-term operating plan, your advisory team should understand both real estate and regulated operations.

Contact us to discuss your strategy.